NAACOS Continues Pushing Forward on the Transition to Value-Based Care

Allison Brennan, MPP, discusses legislation that would affect accountable care organizations (ACOs), the impact coronavirus disease 2019 had on ACOs, and the fall National Association of ACOs meeting.

The move to value-based care has been a long process in the United States, perhaps made even longer by policies that some view as discouraging providers and health systems from participating in alternative payment models and now a pandemic that may stall the transition. As a result of coronavirus disease 2019 (COVID-19), CMS announced it would stop accepting applications for new accountable care organizations in 2021.

However, the National Association of ACOs (NAACOS) is still pushing forward. The organization is supporting new legislation in the House of Representatives that would update Medicare’s ACO program and reward participating ACOs.

Allison Brennan, MPP, senior vice president of government affairs at NAACOS, discusses the new Value in Health Care Act, how other policy changes at CMS have impacted ACOs, and the effect COVID-19 has had on ACOs.

Listen above or through one of these podcast services:


Learn more:

NAACOS Partner Page

NAACOS Fall 2020 Conference Agenda

Related Videos
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr Julie Patterson, National Pharmaceutical Council
Leslie Fish, PharmD.
James Robinson, PhD, MPH, University of California, Berkeley
Related Content
CH LogoCenter for Biosimilars Logo